医学
痰
微生物群
恶化
慢性阻塞性肺病
呼吸道疾病
肺病
肺
重症监护医学
内科学
病理
生物信息学
肺结核
生物
作者
Juan Carlos López Caro,Miguel Santibáñez,Juan Luis Garcia Rivero,Manuel Ángel Villanueva,Jesús Sainz,P. GonzálezAstorqui,Margarita Hierro,M. Rodríguez Porres,Paula Parás‐Bravo,Álex Mira,Juan Carlos Rodrı́guez,Antonio Galiana,on behalf of the ACINAR-microbiome study group
出处
期刊:Respiration
[Karger Publishers]
日期:2019-01-01
卷期号:98 (5): 447-454
被引量:16
摘要
BACKGROUND: Chronic obstructive pulmonary disease (COPD) affects up to 65 million people worldwide, and COPD exacerbation causes tissue damage and subsequent loss of lung function. It is a multifactorial event in which respiratory infections are involved, but little is known about its dynamics. OBJECTIVES: The objective of our study was to determine the microbiome composition during an exacerbation event and post-stabilization. METHODS: We conducted an observational analytical study of a cohort of 55 COPD patients in which 2 sputum samples (the first taken during an exacerbation event and the second during clinical post-stabilization) were submitted to 16s RNA ribosomal analysis by Illumina Miseq Next Generation Sequencing (NGS). The presence of respiratory viruses was also determined. RESULTS: Our study found a stable microbiome composition in the post-stabilization sputum samples of COPD patients, and 4 additional microbiomes in samples taken during the exacerbation, 3 of which showed a marked dysbiosis by Haemophilus, Pseudomonas, and Serratia. The fourth exacerbation microbiome had a very similar composition to post-stabilization samples, but some pathogens such as Moraxella and respiratory viruses were also found. CONCLUSIONS: Our study reveals the main protagonists involved in lung microbiome dynamics during an exacerbation event and post-stabilization in COPD patients by NGS analysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI